Dr. Ntambi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4755 Ogletown Stanton Rd
Newark, DE 19718Phone+1 302-733-1540Fax+1 302-733-6856
Education & Training
- Johns Hopkins UniversityResidency, Nuclear Medicine, 2008 - 2011
- Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 2006 - 2007
- Johns Hopkins University School of MedicineClass of 2006
Certifications & Licensure
- AR State Medical License 2011 - 2026
- DE State Medical License 2019 - 2025
- MD State Medical License 2023 - 2025
- PA State Medical License 2006 - 2007
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- 85 citationsAssessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.James E. McDonald, Marcus M. Kessler, Michael W. Gardner, Amy Buros, James A. Ntambi
Clinical Cancer Research. 2017-04-15 - 44 citationsTreatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myelomaFaith E. Davies, Adam Rosenthal, Leo Rasche, Nathan Petty, James E. McDonald
Haematologica. 2018-06-01 - 14 citationsNeuropeptide Y- and peptide YY-containing colonic cells increase with ageing in male rats.Mark Sweet, James A. Ntambi, Eric A. Gaumnitz, T.D Pugh, R. Weindruch
Neuropeptides. 1996-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: